Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYOpen Medicine

Serum biomarkers and non-invasive indices for discriminating MASLD among adults with dysglycaemia

  • Ünal Kübranur1
  • İbrahimkhanlı Leyla1
  • Erol Mehmet Emre2
  • Altıntop Sabri Engin3
  • İbrahimkhanlı Nemat4
  • Şendur Halit Nahit4
  • Cerit Mahi Nur4
  • Cerit Ethem Turgay3
4 affiliations
  1. 1Department of Medical Biochemistry, Gazi University Faculty of Medicine, Ankara, Türkiye
  2. 2Department of Medical Biochemistry, Institute of Health Sciences, Gazi University, Ankara, Türkiye
  3. 3Department of Endocrinology and Metabolism, Faculty of Medicine, Gazi University, Ankara, Türkiye
  4. 4Department of Radiology, Faculty of Medicine, Gazi University, Ankara, Türkiye
Read full textDOICite

Abstract

Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. Although dysglycaemia is a major risk factor, additional cardiometabolic disturbances contribute to the development of MASLD. This study aimed to identify parameters that distinguish MASLD among dysglycaemic individuals using body composition, anthropometric, biochemical, and imaging-based assessments.

Related

  1. Effects of selenium supplementation on glycemic indices and oxidative-stress biomarkers in adults: a systematic review, meta-analysis, and dose-response analysis of randomized controlled trials.
    Xin-Yue Yang, Pan Xu, Xin Tan +5
    Nutrition journalPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Composite Complete-Blood-Count-Derived Inflammatory Indices for Discriminating Established Major Organ Involvement in Behçet’s Disease: A Cross-Sectional Nomogram Model
    Suleyman Gul, Muammer Özdemir, Hilal Ecesoy
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  3. Interpretable model using serum biomarkers and intra-/peri-aneurysmal CTA radiomics for discriminating ruptured from unruptured intracranial aneurysms: an external validation retrospective study.
    Juan Liu, Zhipeng Chen, Kun Wang +3
    Frontiers in neurologyPeer-reviewedCC BYFull textNeurologyEurope PMCCrossref
  4. Red Cell and Platelet Indices as Biomarkers of Poor Glycemic Control in Patients With Type 2 Diabetes: A Case‐Control Study
    Helen Owusu‐Asante, Samuel Nkansah Darko, Ebenezer Senu +2
    Health science reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response
    Jacobo Rogado, Elisabet González del Portillo, Diego Casado Elía +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref

Cite

BibTeXRIS
BibTeX
@article{kubranur2026serum,
  title = {{Serum biomarkers and non-invasive indices for discriminating MASLD among adults with dysglycaemia}},
  author = {Ünal Kübranur and İbrahimkhanlı Leyla and Erol Mehmet Emre and Altıntop Sabri Engin and İbrahimkhanlı Nemat and Şendur Halit Nahit and Cerit Mahi Nur and Cerit Ethem Turgay},
  journal = {Open Medicine},
  year = {2026},
  month = oct,
  doi = {10.1515/med-2026-1556},
  url = {https://doi.org/10.1515/med-2026-1556},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Serum biomarkers and non-invasive indices for discriminating MASLD among adults with dysglycaemia
AU  - Ünal Kübranur
AU  - İbrahimkhanlı Leyla
AU  - Erol Mehmet Emre
AU  - Altıntop Sabri Engin
AU  - İbrahimkhanlı Nemat
AU  - Şendur Halit Nahit
AU  - Cerit Mahi Nur
AU  - Cerit Ethem Turgay
PY  - 2026
DA  - 2026/10/26
JO  - Open Medicine
DO  - 10.1515/med-2026-1556
UR  - https://doi.org/10.1515/med-2026-1556
AB  - Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. Although dysglycaemia is a major risk factor, additional cardiometabolic disturbances contribute to the development of MASLD. This study aimed to identify parameters that distinguish MASLD among dysglycaemic individuals using body composition, anthropometric, biochemical, and imaging-based assessments.
SN  - 2391-5463
ER  -